Market Screener

Filter stocks by sector, industry, market cap, valuation, growth, and technicals — in a dense table layout.

Reset filters (1 active)

Descriptive Country Sector Industry Index Market Cap Dividend Yield Short Interest (Float) Analyst Rating Earnings Date Avg. Volume Relative Volume Today's Volume Price Price Target IPO Year Shares Outstanding Float

Fundamental P/E Forward P/E PEG P/S P/B P/FCF EV/EBITDA EV/Sales Dividend Growth EPS Growth (Current Year) EPS Growth (Next Year) EPS Growth (Quarter) Revenue Growth (Quarter) Revenue Growth (Year) EPS Surprise (Quarter) Return on Assets (ROA) Return on Equity (ROE) Debt/Equity Gross Margin Operating Margin Net Margin Payout Ratio Insider Ownership Insider Transactions Institutional Ownership Institutional Transactions

Technical Performance Performance 2 Volatility Gap 20-Day Line (EMA 21) 50-Day Line (SMA 50) 200-Day Line (SMA 200) Today's Change 52-Week High/Low All-Time High Beta

Scanner Big Earnings Surprise CANSLIM Type RS Gary Antonacci: Dual Momentum Qullamaggie: Top Gainers 6M Mike Webster: Power-Trend-Leader Mike Webster: Swing Trading List Qullamaggie: Top Gainers 1M Dividend Aristocrats Altman-Z: Fortress Balance Sheet Institutions + CEO Buying QARP — Quality at a Reasonable Price Buffett Criteria (Buffettology) Levermann Piotroski F-Score (7–9) Terry Smith: Quality Fundamental Rank (A/A+) High Revenue Growth EPS Acceleration Quality Growth

Overview Valuation Financials Ownership Performance Technicals Heatmap Results: 1

A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).
No.	Ticker	Company	Sector	Industry	Country	Market Cap ($B) ▼	P/E	Price	Chg. %	Volume
1	LLY	Eli Lilly and Company	Healthcare	Drug Manufacturers - General	US	1,005.6	—	1,152.50	-2.50%	—

A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).

Market Screener

Cookie settings